The global market for contrast media, which was worth approximately $5.23 billion in 2019, is expected to grow at a compound annual growth rate (CAGR) of 3.6% over the next few years, ultimately reaching $6.9 billion by 2027.
“The fundamental factor supporting market growth is diagnostic procedure volumes, stemming from the growing burden of chronic diseases. As per the World Health Organization (WHO), by 2020, chronic diseases will account for three-quarters of global deaths and that 71% to 75% of deaths will be caused by heart diseases. Chronic diseases are preventable and can save patients’ lives if they are diagnosed at an early stage.”
To read more visit Grand View Research.
